Psilocybin
NYC cops crack down on Washington Square Park mushroom sales
The drug dealers tripped up. Cops cracked down on vendors brazenly peddling psilocybin mushrooms from makeshift stalls in Washington Square Park, hours…
The drug dealers tripped up.
Cops cracked down on vendors brazenly peddling psilocybin mushrooms from makeshift stalls in Washington Square Park, hours after The Post last week revealed the extent of the illicit activity.
On July 15 police busted a dealer in the park carrying at least 18 bags of dried shrooms with labels like “Golden Teachers” and “Blue Meanies,” along with several psilocybin-infused Polka Dot-brand candy bars.
Officers also issued two vendor-related summonses, a police spokesperson said.
“The only mushrooms allowed in Washington Square Park are the ones served on your pizza,” the 6th Precinct, which covers the park, tweeted, sharing a photo of the seized stash.
“When caught with these mushrooms, they will be seized and you will be swiftly placed under arrest like the individual today.”
The next day, NYPD showed off a spread of dozens of products taken from the vendors illegally selling ganja in the park.
Neighborhood residents cheered on the arrest Saturday as well as a subsequent uptick in police presence in the park but said cops need to remain vigilant.
“This is being taken seriously,” one resident said.
“Up till now, it just has seemed like everyone was looking the other way, all the time.”
On Thursday afternoon, no vendors were seen hawking narcotics around the fountain, with just one person displaying pre-rolled joints atop a tray table on the eastern side of the park.
“We continue to work in collaboration with NYPD to address unauthorized vending at Washington Square Park,” Parks Department spokeswoman Izzy Verdery said.
“Our priority across our park system is public safety, and we have a fixed post of [Parks Enforcement Patrol] officers assigned to the park daily.”
Additional reporting by Helayne Seidman
The post NYC cops crack down on Washington Square Park mushroom sales appeared first on REPORT DOOR.
psilocybin-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment